Can-Fite BioPharma Ltd. (CANF) — Institutional Holders, Q2 2026

8 institutional investment managers reported a CANF position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $149.1K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

CANF in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

0

Added to

0

Trimmed

3

Sold out

6

Biggest buyers

None this quarter.

Biggest sellers

  1. SABBY MANAGEMENTSold out · -42,559 sh-$126.5K
  2. HRT FINANCIALSold out · -19,383 sh-$57.6K
  3. Virtu FinancialSold out · -12,908 sh-$38.4K
  4. CITIGROUPSold out · -5,482 sh-$16.3K
  5. RHUMBLINE ADVISERSTrimmed · -3,475 sh-$10.3K

CANF 13F holders ranked 1–8 of 8

Institutional investors reporting a position in Can-Fite BioPharma Ltd. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
CITADEL ADVISORS#1 · 32,533 sh$96.6K-4.7%
RHUMBLINE ADVISERS#2 · 17,433 sh$51.8K-16.6%
FIFTH THIRD BANCORP#3 · 150 sh$446.000.0%
WELLS FARGO & COMPANY#4 · 59 sh$175.00-52.8%
Activest Wealth Management#5 · 10 sh$30.000.0%
TD Waterhouse Canada#6 · 1 sh$4.000.0%
MORGAN STANLEY#7 · 1 sh$3.000.0%
Avion Wealth#8 · 5 sh$0.000.0%

Funds that sold out of CANF in Q2 2026 (6)

Held CANF at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held CANF in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
SABBY MANAGEMENT42,559 sh$131.9K
HRT FINANCIAL19,383 sh$60.0K
Virtu Financial12,908 sh$40.0K
CITIGROUP5,482 sh$17.0K
UBS Group AG2,152 sh$6.7K
OSAIC450 sh$1.4K

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.